Global Minor Cannabinoids Market Growth 2025-2031

Publication ID:

LPI03258860

Publication Date:

March 5, 2025

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Minor Cannabinoids market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Minor Cannabinoids is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Minor Cannabinoids is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Minor Cannabinoids is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Minor Cannabinoids players cover FloraWorks, Bright Green Corporation, BayMedica, Colorado Chromatography, Blue Sky Hemp Venture Canadian, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢inor Cannabinoids Industry Forecast鈥� looks at past sales and reviews total world Minor Cannabinoids sales in 2024, providing a comprehensive analysis by region and market sector of projected Minor Cannabinoids sales for 2025 through 2031. With Minor Cannabinoids sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minor Cannabinoids industry.
This Insight Report provides a comprehensive analysis of the global Minor Cannabinoids landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Minor Cannabinoids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Minor Cannabinoids market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minor Cannabinoids and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minor Cannabinoids.
This report presents a comprehensive overview, market shares, and growth opportunities of Minor Cannabinoids market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cannabigerol (CBG)
Cannabichromene (CBC)
Cannabinol (CBN)
Tetrahydrocannabivarin (THCV)
Cannabigerolic Acid (CBGA)
Segmentation by Application:
Medicinal
Edible
Cosmetic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
FloraWorks
Bright Green Corporation
BayMedica
Colorado Chromatography
Blue Sky Hemp Venture Canadian
Sanobiotec
Purisys
Mile High Labs
Cannasouth
Piauhy
Willow Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Minor Cannabinoids market?
What factors are driving Minor Cannabinoids market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Minor Cannabinoids market opportunities vary by end market size?
How does Minor Cannabinoids break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Minor Cannabinoids Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Minor Cannabinoids by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Minor Cannabinoids by Country/Region, 2020, 2024 & 2031
2.2 Minor Cannabinoids Segment by Type
2.2.1 Cannabigerol (CBG)
2.2.2 Cannabichromene (CBC)
2.2.3 Cannabinol (CBN)
2.2.4 Tetrahydrocannabivarin (THCV)
2.2.5 Cannabigerolic Acid (CBGA)
2.3 Minor Cannabinoids Sales by Type
2.3.1 Global Minor Cannabinoids Sales Market Share by Type (2020-2025)
2.3.2 Global Minor Cannabinoids Revenue and Market Share by Type (2020-2025)
2.3.3 Global Minor Cannabinoids Sale Price by Type (2020-2025)
2.4 Minor Cannabinoids Segment by Application
2.4.1 Medicinal
2.4.2 Edible
2.4.3 Cosmetic
2.4.4 Others
2.5 Minor Cannabinoids Sales by Application
2.5.1 Global Minor Cannabinoids Sale Market Share by Application (2020-2025)
2.5.2 Global Minor Cannabinoids Revenue and Market Share by Application (2020-2025)
2.5.3 Global Minor Cannabinoids Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Minor Cannabinoids Breakdown Data by Company
3.1.1 Global Minor Cannabinoids Annual Sales by Company (2020-2025)
3.1.2 Global Minor Cannabinoids Sales Market Share by Company (2020-2025)
3.2 Global Minor Cannabinoids Annual Revenue by Company (2020-2025)
3.2.1 Global Minor Cannabinoids Revenue by Company (2020-2025)
3.2.2 Global Minor Cannabinoids Revenue Market Share by Company (2020-2025)
3.3 Global Minor Cannabinoids Sale Price by Company
3.4 Key Manufacturers Minor Cannabinoids Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Minor Cannabinoids Product Location Distribution
3.4.2 Players Minor Cannabinoids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Minor Cannabinoids by Geographic Region
4.1 World Historic Minor Cannabinoids Market Size by Geographic Region (2020-2025)
4.1.1 Global Minor Cannabinoids Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Minor Cannabinoids Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Minor Cannabinoids Market Size by Country/Region (2020-2025)
4.2.1 Global Minor Cannabinoids Annual Sales by Country/Region (2020-2025)
4.2.2 Global Minor Cannabinoids Annual Revenue by Country/Region (2020-2025)
4.3 Americas Minor Cannabinoids Sales Growth
4.4 APAC Minor Cannabinoids Sales Growth
4.5 Europe Minor Cannabinoids Sales Growth
4.6 Middle East & Africa Minor Cannabinoids Sales Growth
5 Americas
5.1 Americas Minor Cannabinoids Sales by Country
5.1.1 Americas Minor Cannabinoids Sales by Country (2020-2025)
5.1.2 Americas Minor Cannabinoids Revenue by Country (2020-2025)
5.2 Americas Minor Cannabinoids Sales by Type (2020-2025)
5.3 Americas Minor Cannabinoids Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minor Cannabinoids Sales by Region
6.1.1 APAC Minor Cannabinoids Sales by Region (2020-2025)
6.1.2 APAC Minor Cannabinoids Revenue by Region (2020-2025)
6.2 APAC Minor Cannabinoids Sales by Type (2020-2025)
6.3 APAC Minor Cannabinoids Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Minor Cannabinoids by Country
7.1.1 Europe Minor Cannabinoids Sales by Country (2020-2025)
7.1.2 Europe Minor Cannabinoids Revenue by Country (2020-2025)
7.2 Europe Minor Cannabinoids Sales by Type (2020-2025)
7.3 Europe Minor Cannabinoids Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Minor Cannabinoids by Country
8.1.1 Middle East & Africa Minor Cannabinoids Sales by Country (2020-2025)
8.1.2 Middle East & Africa Minor Cannabinoids Revenue by Country (2020-2025)
8.2 Middle East & Africa Minor Cannabinoids Sales by Type (2020-2025)
8.3 Middle East & Africa Minor Cannabinoids Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Minor Cannabinoids
10.3 Manufacturing Process Analysis of Minor Cannabinoids
10.4 Industry Chain Structure of Minor Cannabinoids
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Minor Cannabinoids Distributors
11.3 Minor Cannabinoids Customer
12 World Forecast Review for Minor Cannabinoids by Geographic Region
12.1 Global Minor Cannabinoids Market Size Forecast by Region
12.1.1 Global Minor Cannabinoids Forecast by Region (2026-2031)
12.1.2 Global Minor Cannabinoids Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Minor Cannabinoids Forecast by Type (2026-2031)
12.7 Global Minor Cannabinoids Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 FloraWorks
13.1.1 FloraWorks Company Information
13.1.2 FloraWorks Minor Cannabinoids Product Portfolios and Specifications
13.1.3 FloraWorks Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 FloraWorks Main Business Overview
13.1.5 FloraWorks Latest Developments
13.2 Bright Green Corporation
13.2.1 Bright Green Corporation Company Information
13.2.2 Bright Green Corporation Minor Cannabinoids Product Portfolios and Specifications
13.2.3 Bright Green Corporation Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bright Green Corporation Main Business Overview
13.2.5 Bright Green Corporation Latest Developments
13.3 BayMedica
13.3.1 BayMedica Company Information
13.3.2 BayMedica Minor Cannabinoids Product Portfolios and Specifications
13.3.3 BayMedica Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BayMedica Main Business Overview
13.3.5 BayMedica Latest Developments
13.4 Colorado Chromatography
13.4.1 Colorado Chromatography Company Information
13.4.2 Colorado Chromatography Minor Cannabinoids Product Portfolios and Specifications
13.4.3 Colorado Chromatography Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Colorado Chromatography Main Business Overview
13.4.5 Colorado Chromatography Latest Developments
13.5 Blue Sky Hemp Venture Canadian
13.5.1 Blue Sky Hemp Venture Canadian Company Information
13.5.2 Blue Sky Hemp Venture Canadian Minor Cannabinoids Product Portfolios and Specifications
13.5.3 Blue Sky Hemp Venture Canadian Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Blue Sky Hemp Venture Canadian Main Business Overview
13.5.5 Blue Sky Hemp Venture Canadian Latest Developments
13.6 Sanobiotec
13.6.1 Sanobiotec Company Information
13.6.2 Sanobiotec Minor Cannabinoids Product Portfolios and Specifications
13.6.3 Sanobiotec Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sanobiotec Main Business Overview
13.6.5 Sanobiotec Latest Developments
13.7 Purisys
13.7.1 Purisys Company Information
13.7.2 Purisys Minor Cannabinoids Product Portfolios and Specifications
13.7.3 Purisys Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Purisys Main Business Overview
13.7.5 Purisys Latest Developments
13.8 Mile High Labs
13.8.1 Mile High Labs Company Information
13.8.2 Mile High Labs Minor Cannabinoids Product Portfolios and Specifications
13.8.3 Mile High Labs Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mile High Labs Main Business Overview
13.8.5 Mile High Labs Latest Developments
13.9 Cannasouth
13.9.1 Cannasouth Company Information
13.9.2 Cannasouth Minor Cannabinoids Product Portfolios and Specifications
13.9.3 Cannasouth Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cannasouth Main Business Overview
13.9.5 Cannasouth Latest Developments
13.10 Piauhy
13.10.1 Piauhy Company Information
13.10.2 Piauhy Minor Cannabinoids Product Portfolios and Specifications
13.10.3 Piauhy Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Piauhy Main Business Overview
13.10.5 Piauhy Latest Developments
13.11 Willow Biosciences
13.11.1 Willow Biosciences Company Information
13.11.2 Willow Biosciences Minor Cannabinoids Product Portfolios and Specifications
13.11.3 Willow Biosciences Minor Cannabinoids Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Willow Biosciences Main Business Overview
13.11.5 Willow Biosciences Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂